Aurora(US:ACB) ZACKS·2025-08-06 13:51Group 1: Earnings Performance - Aurora Cannabis Inc. reported a quarterly loss of $0.19 per share, compared to the Zacks Consensus Estimate of $0.18, and a loss of $0.11 per share a year ago, indicating an earnings surprise of -205.56% [1] - The company posted revenues of $75.49 million for the quarter ended June 2025, surpassing the Zacks Consensus Estimate by 6.50%, and compared to year-ago revenues of $67.27 million [2] - Over the last four quarters, Aurora Cannabis has surpassed consensus EPS estimates two times and topped consensus revenue estimates four times [2] Group 2: Stock Performance and Outlook - Aurora Cannabis shares have increased by approximately 8.2% since the beginning of the year, outperforming the S&P 500's gain of 7.1% [3] - The company's earnings outlook, including current consensus earnings expectations for upcoming quarters, will be crucial for investors [4] - The current consensus EPS estimate for the coming quarter is $0.09 on revenues of $65.3 million, and $0.56 on revenues of $272.14 million for the current fiscal year [7] Group 3: Industry Context - The Medical - Products industry, to which Aurora Cannabis belongs, is currently ranked in the bottom 41% of over 250 Zacks industries, indicating potential challenges for stock performance [8] - Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can impact investor decisions [5]